These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 2598189)
1. Augmentative effect of Nocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s). Shirasaka T; Kawase I; Okada M; Kitahara M; Ikeda T; Komuta K; Hosoe S; Yokota S; Masuno T; Kishimoto S Cancer Immunol Immunother; 1989; 30(4):195-204. PubMed ID: 2598189 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells. Kawase I; Shirasaka T; Ikeda T; Hara H; Tanio Y; Watanabe M; Saito S; Masuno T; Kishimoto S; Yamamura Y Jpn J Cancer Res; 1989 Nov; 80(11):1098-105. PubMed ID: 2481664 [TBL] [Abstract][Full Text] [Related]
3. Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity. Kawase I; Komuta K; Shirasaka T; Hara H; Tanio Y; Watanabe M; Saito S; Ikeda T; Masuno T; Kishimoto S Jpn J Cancer Res; 1989 Nov; 80(11):1089-97. PubMed ID: 2514171 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of Nocardia rubra cell wall skeleton and recombinant interleukin 2 for in vivo induction of lymphokine-activated killer cells. Miyazaki K; Yasumoto K; Yano T; Matsuzaki G; Sugimachi K; Nomoto K Cancer Res; 1991 Oct; 51(19):5261-5. PubMed ID: 1833049 [TBL] [Abstract][Full Text] [Related]
5. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906 [TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction. Stewart-Akers AM; Cairns JS; Tweardy DJ; McCarthy SA Blood; 1993 May; 81(10):2671-8. PubMed ID: 8490177 [TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated effector cells: modulation of activity by cytokines. Mehta S; Flanagan P; Blackinton D; Wanebo H Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419 [TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro. Findley HW; Nasr S; Afify Z; Hnath R; Waldrep K; Ragab AH Cancer Invest; 1990; 8(5):493-500. PubMed ID: 2124946 [TBL] [Abstract][Full Text] [Related]
10. Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors. Miller JS; Verfaillie C; McGlave P Blood; 1991 Jun; 77(11):2389-95. PubMed ID: 1903991 [TBL] [Abstract][Full Text] [Related]
11. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177 [TBL] [Abstract][Full Text] [Related]
12. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. Mulé JJ; Krosnick JA; Rosenberg SA J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. Chong AS; Boussy IA; Graf LH; Scuderi P Cell Immunol; 1992 Oct; 144(1):69-79. PubMed ID: 1356634 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells. Grant AJ; Merchant RE; Hall RE Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273 [TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation. Thompson RA; Ballas ZK J Immunol; 1990 Nov; 145(10):3524-31. PubMed ID: 1700014 [TBL] [Abstract][Full Text] [Related]
16. Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs. Heaton KM; Ju G; Grimm EA Ann Surg Oncol; 1994 May; 1(3):198-203. PubMed ID: 7842289 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. Alderson MR; Sassenfeld HM; Widmer MB J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722 [TBL] [Abstract][Full Text] [Related]
18. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565. Sodhi A; Basu S Nat Immun; 1992; 11(2):105-16. PubMed ID: 1498519 [TBL] [Abstract][Full Text] [Related]